0,946  0,003  CYP1A2 substrate
0,898  0,003  CYP2C19 substrate
0,877  0,004  CYP2D6 substrate
0,874  0,004  CYP2C9 substrate
0,856  0,005  TNF expression inhibitor
0,753  0,004  Carcinogenic, group 3
0,732  0,015  CYP3A4 substrate
0,691  0,017  Teratogen
0,677  0,007  Eye irritation, high
0,669  0,017  Embryotoxic
0,629  0,015  Antiprotozoal
0,615  0,010  Antiprotozoal (Plasmodium)
0,509  0,013  Antineoplastic (non-Hodgkin's lymphoma)
0,511  0,019  Caspase 3 stimulant
0,529  0,042  MAP kinase 1 inhibitor
0,452  0,014  Skin irritative effect
0,430  0,005  p38 MAP kinase inhibitor
0,480  0,062  Antiarthritic
0,415  0,005  Aldehyde dehydrogenase inhibitor
0,395  0,004  AXL receptor tyrosine kinase inhibitor
0,392  0,032  Antiprotozoal (Leishmania)
0,376  0,027  Psychostimulant
0,372  0,032  Dyrk kinase inhibitor
0,374  0,035  Carcinogenic
0,341  0,004  Phosphodiesterase 4A inhibitor
0,363  0,033  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,359  0,029  Antineoplastic (endocrine cancer)
0,372  0,045  Cardioprotectant
0,393  0,066  Antineoplastic (myeloid leukemia)
0,398  0,079  5 Hydroxytryptamine release inhibitor
0,341  0,032  DNA synthesis inhibitor
0,299  0,005  Antifungal (Cryptococcus)
0,315  0,029  RNA-directed DNA polymerase inhibitor
0,286  0,006  CDK1/cyclin B inhibitor
0,317  0,043  Acute neurologic disorders treatment
0,336  0,068  Immunostimulant
0,273  0,013  Cyclin-dependent kinase 5 inhibitor
0,296  0,045  Mutagenic
0,261  0,019  Cyclin-dependent kinase 7 inhibitor
0,256  0,015  MAP kinase 9 inhibitor
0,290  0,050  5 Hydroxytryptamine uptake stimulant
0,241  0,004  Transcription factor AP-1 inhibitor
0,249  0,014  CDK/cyclin complex inhibitor
0,308  0,078  Immunomodulator
0,303  0,075  Respiratory analeptic
0,231  0,005  Cyclin E1 inhibitor
0,297  0,077  Analeptic
0,237  0,018  Cyclin-dependent kinase 2 inhibitor
0,227  0,010  Carbonic anhydrase VI inhibitor
0,249  0,032  Antiviral (Herpes)
0,219  0,005  Cyclin E inhibitor
0,241  0,029  Cyclin-dependent kinase inhibitor
0,216  0,007  Potassium channel activator
0,297  0,089  FMO1 substrate
0,244  0,042  Antiviral (West Nile virus)
0,246  0,045  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,210  0,010  Adenosine A2 receptor antagonist
0,210  0,009  Adenosine A2a receptor antagonist
0,203  0,003  Catechol O-methyltransferase inhibitor
0,309  0,109  Immunosuppressant
0,260  0,063  Cytostatic
0,203  0,011  Adenosine A1 receptor antagonist
0,209  0,017  CF transmembrane conductance regulator agonist
0,212  0,022  Protein kinase (CK2) alpha inhibitor
0,187  0,002  Prolactin release inhibitor
0,189  0,009  CDC-like kinase 3 inhibitor
0,219  0,043  Tumour necrosis factor antagonist
0,189  0,015  Carbonic anhydrase XIII inhibitor
0,183  0,010  CDK1/cyclin B1 inhibitor
0,275  0,110  Vasodilator, coronary
0,182  0,017  CDK2/cyclin A inhibitor
0,198  0,035  Alpha-N-acetylglucosaminidase inhibitor
0,185  0,022  Protein kinase (CK2) inhibitor
0,169  0,013  Neutropenia treatment
0,162  0,009  Purinergic P2X2 antagonist
0,159  0,007  Androgen agonist
0,163  0,011  Adenosine A3 receptor antagonist
0,249  0,097  Antineoplastic (multiple myeloma)
0,194  0,043  Lck kinase inhibitor
0,153  0,005  Carbonic anhydrase XIV inhibitor
0,189  0,042  CDC-like kinase 1 inhibitor
0,161  0,014  MAP kinase 10 inhibitor
0,189  0,044  Heat shock protein 90 antagonist
0,191  0,048  Antineoplastic (bone cancer)
0,237  0,095  5 Hydroxytryptamine release stimulant
0,315  0,173  Antineoplastic (solid tumors)
0,230  0,090  Tyrosine 3 hydroxylase inhibitor
0,137  0,005  Phosphodiesterase VII inhibitor
0,141  0,011  MAP kinase kinase 10 inhibitor
0,163  0,033  Antineoplastic antimetabolite
0,262  0,133  GST A substrate
0,154  0,026  Insulin receptor antagonist
0,196  0,069  5 Hydroxytryptamine 3E antagonist
0,129  0,002  Purinergic P2X agonist
0,130  0,004  Phosphodiesterase 7A inhibitor
0,144  0,020  MAP kinase 14 inhibitor
0,141  0,017  CXC chemokine 4 receptor antagonist
0,223  0,101  Antiprotozoal (Trypanosoma)
0,127  0,006  Histamine agonist
0,306  0,187  Caspase 9 stimulant
0,121  0,004  Cyclin H inhibitor
0,123  0,007  Cyclin B inhibitor
0,134  0,019  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,117  0,004  Aggrecanase 1 inhibitor
0,132  0,019  Carbonic anhydrase inhibitor
0,136  0,023  Aminoacyl-tRNA synthetase inhibitor
0,128  0,017  Cyclin A2 inhibitor
0,118  0,008  Adenosine A2b receptor antagonist
0,141  0,033  MAP kinase 8 inhibitor
0,179  0,075  Diabetic retinopathy treatment
0,121  0,017  CDK2/cyclin E inhibitor
0,118  0,014  Carbonic anhydrase I inhibitor
0,121  0,021  Carbonic anhydrase V inhibitor
0,115  0,015  Carbonic anhydrase II inhibitor
0,118  0,018  Carbonic anhydrase VA inhibitor
0,157  0,058  MAP kinase 3 inhibitor
0,104  0,005  CDK7/cyclin H inhibitor
0,115  0,017  Carbonic anhydrase IX inhibitor
0,184  0,087  Amyloid beta aggregation inhibitor
0,122  0,024  Protein kinase B gamma inhibitor
0,198  0,103  Aryl hydrocarbon receptor agonist
0,098  0,003  Adenosine A3 receptor agonist
0,108  0,014  Carbonic anhydrase VB inhibitor
0,112  0,018  I kappa B kinase 1 inhibitor
0,113  0,019  Cyclin A inhibitor
0,200  0,106  Cardiovascular analeptic
0,166  0,073  Src kinase inhibitor
0,207  0,116  Proliferative diseases treatment
0,094  0,005  Potassium channel (Inward rectifier) activator
0,246  0,158  GABA C receptor rho-3 antagonist
0,212  0,126  Radiosensitizer
0,091  0,005  Potassium channel (ATP-sensitive) activator
0,107  0,022  Sodium/hydrogen exchanger 5 inhibitor
0,110  0,025  CDK2/cyclin E2 inhibitor
0,086  0,005  Purinergic P2Y2 antagonist
0,083  0,002  Antineoplastic (insulinoma)
0,165  0,084  LIM domain kinase 1 inhibitor
0,151  0,072  Antianorexic
0,087  0,008  Phosphoglycerate kinase inhibitor
0,106  0,029  Histamine H2 receptor antagonist
0,102  0,027  Interferon agonist
0,233  0,158  Stroke treatment
0,179  0,106  Antiparkinsonian, rigidity relieving
0,169  0,096  Ca2+/calmodulin-dependent protein kinase inhibitor
0,293  0,222  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,139  0,069  CNS active muscle relaxant
0,096  0,027  CXC chemokine receptor antagonist
0,095  0,028  Sleep apnea treatment
0,134  0,067  Antiprotozoal (Trichomonas)
0,114  0,047  Fibroblast growth factor 1 antagonist
0,250  0,184  Antiparkinsonian
0,114  0,048  GST T1-1 substrate
0,174  0,108  Angiogenesis stimulant
0,107  0,042  Carcinogenic, group 2A
0,120  0,055  CDK3/cyclin E inhibitor
0,112  0,049  Antineoplastic, alkylator
0,083  0,019  Cyclin B1 inhibitor
0,083  0,021  Interferon inducer
0,210  0,149  FMO3 substrate
0,077  0,020  Corticotropin releasing factor 2 receptor antagonist
0,061  0,004  Histamine H4 receptor agonist
0,075  0,018  Cyclin B2 inhibitor
0,060  0,005  Adenosine A1 receptor agonist
0,205  0,151  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,058  0,005  Corticotropin releasing factor 1 receptor antagonist
0,079  0,026  Carbonic anhydrase XII inhibitor
0,108  0,055  Butyrylcholinesterase inhibitor
0,098  0,046  Phosphodiesterase IV inhibitor
0,104  0,053  Interleukin 1 beta converting enzyme inhibitor
0,165  0,115  Antiparasitic
0,068  0,018  Potassium channel (Inward rectifier) blocker
0,134  0,085  Antiprotozoal (Coccidial)
0,097  0,047  NADH dehydrogenase inhibitor
0,179  0,131  Nitric-oxide synthase stimulant
0,148  0,101  Cyclin-dependent kinase 3 inhibitor
0,077  0,031  Potassium channel (ATP-sensitive) blocker
0,190  0,146  Flavin-containing monooxygenase substrate
0,095  0,051  Antidote, mercury
0,047  0,004  Adenosine A2 receptor agonist
0,237  0,196  Transcription factor inhibitor
0,049  0,008  Protein kinase (CK2) beta inhibitor
0,101  0,061  Carbonic anhydrase III inhibitor
0,084  0,044  Vanilloid antagonist
0,124  0,085  Cytokine production inhibitor
0,055  0,020  CC chemokine 4 receptor antagonist
0,059  0,024  Anesthetic inhalation
0,127  0,093  Peroxidase inhibitor
0,037  0,004  Adenosine A2a receptor agonist
0,168  0,136  Tumour necrosis factor alpha release inhibitor
0,163  0,131  Antineoplastic (lymphocytic leukemia)
0,063  0,032  Cyclin A1 inhibitor
0,099  0,068  GABA C receptor agonist
0,087  0,058  Insulin growth factor antagonist
0,159  0,129  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,084  0,056  Insulin like growth factor 1 antagonist
0,147  0,120  Antiviral (Hepatitis)
0,051  0,024  Potassium channel small-conductance Ca-activated blocker
0,181  0,156  Neuropeptide Y2 antagonist
0,046  0,023  Nicotinic acid receptor 1 agonist
0,027  0,004  Adenosine A2b receptor agonist
0,093  0,071  Cyclin-dependent kinase 1 inhibitor
0,051  0,029  Histamine H4 receptor antagonist
0,060  0,040  CDK9/cyclin T1 inhibitor
0,096  0,076  Ferrochelatase inhibitor
0,071  0,052  Telomerase inhibitor
0,075  0,057  Narcotic antagonist
0,148  0,130  Antirickettsial
0,154  0,136  Antiglaucomic
0,036  0,020  Adenosine uptake inhibitor
0,126  0,113  Muscle relaxant
0,185  0,171  Hypoxia-inducible factor 1 alpha inhibitor
0,169  0,156  Superoxide dismutase inhibitor
0,119  0,108  Aurora-C kinase inhibitor
0,021  0,010  Cyclin T1 inhibitor
0,103  0,092  MAP kinase kinase inhibitor
0,019  0,009  Purinergic P2Y1 antagonist
0,104  0,095  Transcription factor STAT6 inhibitor
0,124  0,116  Adenylate cyclase stimulant
0,053  0,045  Immunoglobulin Fc receptor antagonist
0,040  0,033  Carbonic anhydrase IV inhibitor
0,083  0,076  Platelet activating factor beta antagonist
0,041  0,035  Purinergic P2Y antagonist
0,065  0,060  Aminopeptidase I inhibitor
0,061  0,056  CDC7 inhibitor
0,055  0,051  Gonadotropin-releasing hormone receptor agonist
0,107  0,104  DNA repair enzyme inhibitor
0,129  0,126  Antiviral (Hepatitis C)
0,006  0,003  P2 nucleoside transporter inhibitor
0,094  0,092  Protein kinase (CK1) gamma 2 inhibitor
0,038  0,037  Histamine H2 receptor agonist
0,108  0,107  Antihelmintic (Trematoda)
0,081  0,080  Aminopeptidase B inhibitor
0,078  0,077  T cell inhibitor
0,015  0,014  CDK2/cyclin A3 inhibitor

